Home-Based Testing Firm EverlyWell Raises $50M

Apr 16, 2019

|

NEW YORK (360Dx) – Home-based testing firm EverlyWell today announced it had raised $50 million to expand its digital platform and scale existing partnerships with companies including CVS and Humana.

The financing was led by existing investor Goodwater Capital. Highland Capital Partners also participated in the financing.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

Home-Based Testing Firm EverlyWell Raises $50M

To read the full story....

Breaking News

FDA Issues EUA for Adaptive Biotechnologies COVID-19 T-Cell Response Test

Cue Health Over-the-Counter COVID-19 Test Gets FDA Emergency Use Authorization

German Stores to Begin Selling COVID-19 Rapid Antigen Tests for Home Use

Abbott Gets FDA EUA for Test That Detects Coronavirus, Three Other Respiratory Infections

Illumina Receives Medical Device Registration in Russia for NextSeq 550 Dx Sequencer, Reagents

DermTech Q4 Revenues Up 31 Percent

What's Popular?

Abbott Gets FDA EUA for Test That Detects Coronavirus, Three Other Respiratory Infections

OraSure Technologies Updates Plan for SARS-CoV-2 Antigen Self-Test

Fulgent Genetics Aims to Use COVID-19 Testing Gains to Grow Clinical Sequencing Business

Illumina Receives Medical Device Registration in Russia for NextSeq 550 Dx Sequencer, Reagents

Norwegian Startup Pre Diagnostics Developing Monocyte Test for Presymptomatic Alzheimer's Disease

Sponsorships